The manufacturing of medicinal products is for us not only a matter of implementing a certain technological process, but a human mission based on high standards of quality, safety and efficacy of medications
In his inaugural speech at the 21st Annual Conference of the European Generic and Biosimilar Medicines Association (EGA), EGA President Mr Nick Haggar said that the European industry for generic and biosimilar medicines “fulfils its mission by providing high quality medicines for patients in Europe, increasing their access to effective treatment and partnering for sustainable healthcare”.
According to one of the purposes of the latest healthcare strategy, Bulgaria has to spend more public funds for medical treatment of patients with generic medicines, which are much cheaper than the original drugs. Thus, this country would be able to save a substantial amount of money. Chairman of the Board of Directors of Sopharma pharmaceutical company Ognian Donev told Radio Bulgaria that the authorities have to put more efforts into the country’s pro-generic medicine policy: “We are still waiting to see real policy in this field.
Вчера, 09.07.2015, по време на оспорваната надпревара на Европейския тенис турнир за ветерани на НТЦ беше открит иновативен еко веловръз „Здрави”. Той е първият от серия стойки за велосипеди, с която приключи „sopharmabike”, съвместен проект на Софарма, Драг и Дарик.
Веловръзът” Здрави” е за 12 велосипеда и е поставен на тенис кортовете в Борисовата градина.
A new study published in the journal Addiction suggests countries have no excuse for not helping their citizens quit smoking. With tobacco still the leading cause of preventable death worldwide, killing some 5 million people annually, even the poorest countries can do their part. The international team of researchers behind the study offer up six methods that are globally affordable and shown to work. 1.
Sopharma is among the 17 Bulgarian companies in the Top 500 of the international credit insurer - Coface CEE.The ranking is for the largest companies in Central and Eastern Europe and has been published for the seventh consecutive year.The Bulgarian companies for 2014 are 17 and their total turnover reached 17.99 billion euros, which is 4.24% growth. The total turnover of all companies included in the ranking is 572 billion euros. http://www.darikfinance.bg/novini/117441
